The members of the American Society for Radiation Oncology recently elected five new officers to ASTRO’s board of directors.
Thyme Care announced the close of a $95 million capital raise. With $55 million in equity funding, Thyme Care welcomes new investor Concord Health Partners with participation from all existing investors, including CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures, and Foresite Capital.
Lei Zheng was named executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and vice president for oncology for the University of Texas Health Science Center at San Antonio.
Mark Burkard was named director of University of Iowa Health Care Holden Comprehensive Cancer Center.
Glen Barber was named director of the Center for Innate Immunity and Inflammation within the Pelotonia Institute for Immuno-Oncology at the Ohio State University Comprehensive Cancer Center—James Cancer Hospital and Solove Research Institute.
Tiffany Seagroves joined the Tulane Cancer Center and Tulane University School of Medicine as a professor in the John W. Deming Department of Medicine, Section of Hematology and Medical Oncology.
Linda Liau, chair of neurosurgery at the David Geffen School of Medicine at UCLA, was elected as an Academician of Academia Sinica by the 35th Convocation of Academicians, the preeminent academic institution in Taiwan.
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.8 million grant from NCI to advance their work in personalizing cancer treatment.
Sanaz Memarzadeh of UCLA has received two grants totaling $4.1 million to develop advanced cell-based immune therapies for high-grade serous ovarian cancers that have become resistant to conventional treatments.
The University of Arkansas for Medical Sciences has been awarded a $1.3 million grant from NIH for its Arkansas Technology and Data Science in Health and Medicine program.
